About Ergomed
Ergomed is a company based in Guildford (United Kingdom) founded in 1997 was acquired by Permira in September 2023. Ergomed has completed 9 acquisitions, including ADAMAS Consulting, Ergomed and GASD. Ergomed offers products and services including Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting. Ergomed operates in a competitive market with competitors including hVIVO, Chiltern International, ClinTec, Avillion and Celadon Pharmaceuticals, among others.
- Headquarter Guildford, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ergomed Plc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$5.53 M (USD), Post-IPO
Feb 01, 2018
-
Investors
Permira
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
ADAMAS Consulting
& 8 more
-
Acquired by
Permira
(Sep 04, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ergomed
Ergomed offers a comprehensive portfolio of products and services, including Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting.
Full-service CRO for oncology and rare diseases trials
End-to-end PV services from clinical development to post-marketing
Full range of GxP audits for drug development and surveillance
People of Ergomed
Unlock access to complete
Funding Insights of Ergomed
Investors in Ergomed
Ergomed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and Catapult Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked | |
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Locked | Locked | Locked |
Investor details for Ergomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ergomed
Ergomed has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include ADAMAS Consulting, Ergomed and GASD.
Investment portfolio details for Ergomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmacovigilance and regulatory services are provided to pharmaceutical firms.
|
Locked | Locked | 2010 | Locked | |
|
Pharmacovigilance and regulatory services for drugs and devices are provided.
|
Locked | Locked | 2008 | Locked | |
|
Functional CRO offering pharmacovigilance services
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Ergomed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ergomed
Detailed financials for Ergomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ergomed Comparisons
Peer comparison for Ergomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ergomed
Ergomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as hVIVO, Chiltern International, ClinTec, Avillion and Celadon Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of cell based assays, field trial, and molecular services for biopharma sector
|
|
| Locked | Locked | Locked |
Full service CRO with expertise in oncology related development services
|
|
| Locked | Locked | Locked |
Clinical research services are provided globally to pharmaceutical industries.
|
|
| Locked | Locked | Locked |
Clinical co-development services and financing for late-stage therapeutics are provided.
|
|
| Locked | Locked | Locked |
Provider of cannabis trial services
|
Detailed competitors of Ergomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ergomed
Complete news archive for Ergomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ergomed
Ergomed was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Ergomed is headquartered in Guildford, United Kingdom.
Ergomed is a CRO operating in 50 countries with two complementary businesses. As part of its co-development business, the company offers drug development services in exchange for revenues and out-licensing milestones w.r.t the sale and development of the product. The company has signed 5 such deals so far with different pharma companies. The company has acquired Haemostatix, along with a pipeline of proprietary development products for haemostasis in surgical settings.
Ergomed's top competitors include hVIVO, Chiltern International and Avillion.
Ergomed offers Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting.
Ergomed has made 9 acquisitions, including ADAMAS Consulting, Ergomed, and GASD.
Ergomed has 2 investors. Key investors include Permira, and Catapult Ventures.